Family Health Centers of San Diego INC
Family Health Centers of San Diego INC was paid $3.79M by Medicaid between Jan 2018 and Jul 2024, across 75 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 100% of everything it billed.
CHULA VISTA, CA 91911
Next to other Federally Qualified Health Center (FQHC) providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,172 | $800K | |
| 2019 | 13,442 | $727K | |
| 2020 | 8,142 | $445K | |
| 2021 | 1,571 | $115K | |
| 2022 | 7,640 | $513K | |
| 2023 | 14,101 | $911K | |
| 2024incomplete | 4,239 | $279K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 100% | 28,510 | 23,955 | $3.78M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 432 | 370 | $7K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 12 | 12 | $2K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 6,316 | 5,837 | $1K |
| 93000 | <1% | 28 | 28 | $599.20 | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 5,071 | 4,714 | $429.36 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 306 | 306 | $405.20 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 817 | 816 | $369.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,416 | 1,406 | $368.92 |
| 80061 | Lipid panel | <1% | 949 | 947 | $346.20 |
| 80053 | Comprehensive metabolic panel | <1% | 1,120 | 1,109 | $330.84 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 959 | 954 | $310.50 |
63 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 926 | $222.04 |
| 98960 | <1% | 20 | $215.20 | |
| 82951 | <1% | 16 | $203.29 | |
| 81002 | <1% | 75 | $161.25 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,743 | $126.70 |
| 86592 | <1% | 221 | $86.52 | |
| 81025 | <1% | 92 | $84.66 | |
| 96127 | <1% | 443 | $75.36 | |
| 87210 | <1% | 54 | $65.42 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 182 | $31.17 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 182 | $31.07 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,035 | $13.50 |
| 86803 | <1% | 88 | $12.57 | |
| 85018 | <1% | 152 | $4.14 | |
| 97803 | 0% | 1,382 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 310 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 158 | $0.00 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 228 | $0.00 |
| 99173 | 0% | 697 | $0.00 | |
| 90756 | 0% | 326 | $0.00 | |
| 90461 | 0% | 26 | $0.00 | |
| 83540 | 0% | 25 | $0.00 | |
| 82947 | 0% | 21 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 86 | $0.00 |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 0% | 12 | $0.00 |
| 96160 | 0% | 24 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 31 | $0.00 |
| 86480 | 0% | 26 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 81 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 25 | $0.00 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 134 | $0.00 |
| 81003 | 0% | 89 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 114 | $0.00 |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 67 | $0.00 |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 0% | 37 | $0.00 |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 12 | $0.00 |
| 82274 | 0% | 17 | $0.00 | |
| 99404 | 0% | 18 | $0.00 | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | 0% | 15 | $0.00 |
| 99401 | 0% | 17 | $0.00 | |
| 87340 | 0% | 46 | $0.00 | |
| 92551 | 0% | 481 | $0.00 | |
| 97802 | 0% | 200 | $0.00 | |
| 90686 | 0% | 187 | $0.00 | |
| 86704 | 0% | 110 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 109 | $0.00 |
| 94760 | 0% | 54 | $0.00 | |
| 86706 | 0% | 131 | $0.00 | |
| 99000 | 0% | 221 | $0.00 | |
| 82728 | 0% | 12 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 20 | $0.00 |
| 99406 | 0% | 31 | $0.00 | |
| 81015 | 0% | 57 | $0.00 | |
| 90674 | 0% | 154 | $0.00 | |
| 87428 | 0% | 13 | $0.00 | |
| 81001 | 0% | 100 | $0.00 | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 0% | 38 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 14 | $0.00 |
| 87070 | 0% | 110 | $0.00 | |
| 83550 | 0% | 12 | $0.00 | |
| 99459 | 0% | 12 | $0.00 | |
| 90677 | 0% | 19 | $0.00 | |
| H0001 | Alcohol and/or drug assessment | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.